Literature DB >> 12445556

A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid.

True L Rogers1, Andrew C Nelsen, Jiahui Hu, Judith N Brown, Marazban Sarkari, Timothy J Young, Keith P Johnston, Robert O Williams.   

Abstract

A novel cryogenic spray-freezing into liquid (SFL) process was developed to produce microparticulate powders consisting of an active pharmaceutical ingredient (API) molecularly embedded within a pharmaceutical excipient matrix. In the SFL process, a feed solution containing the API was atomized beneath the surface of a cryogenic liquid such that the liquid-liquid impingement between the feed and cryogenic liquids resulted in intense atomization into microdroplets, which were frozen instantaneously into microparticles. The SFL micronized powder was obtained following lyophilization of the frozen microparticles. The objective of this study was to develop a particle engineering technology to produce micronized powders of the hydrophobic drug, danazol, complexed with hydroxypropyl-beta-cyclodextrin (HPbetaCD) and to compare these SFL micronized powders to inclusion complex powders produced from other techniques, such as co-grinding of dry powder mixtures and lyophilization of bulk solutions. Danazol and HPbetaCD were dissolved in a water/tetrahydrofuran cosolvent mixture prior to SFL processing or slow freezing. Identical quantities of the API and HPbetaCD used in the solutions were co-ground in a mortar and pestle and blended to produce a co-ground physical mixture for comparison. The powder samples were characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (XRD), Fourier transform infrared spectrometry (FTIR), scanning electron microscopy, surface area analysis, and dissolution testing. The results provided by DSC, XRD, and FTIR suggested the formation of inclusion complexes by both slow-freezing and SFL. However, the specific surface area was significantly higher for the latter. Dissolution results suggested that equilibration of the danazol/HPbetaCD solution prior to SFL processing was required to produce the most soluble conformation of the resulting inclusion complex following SFL. SFL micronized powders exhibited better dissolution profiles than the slowly frozen aggregate powder. Results indicated that micronized SFL inclusion complex powders dissolved faster in aqueous dissolution media than inclusion complexes formed by conventional techniques due to higher surface areas and stabilized inclusion complexes obtained by ultra-rapid freezing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445556     DOI: 10.1016/s0939-6411(02)00063-2

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  15 in total

1.  Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.

Authors:  Xiuqiong He; Lixia Pei; Henry H Y Tong; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs.

Authors:  True L Rogers; Ian B Gillespie; James E Hitt; Kevin L Fransen; Cindy A Crowl; Christopher J Tucker; Gary B Kupperblatt; Joe N Becker; Deb L Wilson; Clifford Todd; Charles F Broomall; Jonathan C Evans; Edmund J Elder
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

3.  In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.

Authors:  Barbara J Hoeben; David S Burgess; Jason T McConville; Laura K Najvar; Robert L Talbert; Jay I Peters; Nathan P Wiederhold; Bradi L Frei; John R Graybill; Rosie Bocanegra; Kirk A Overhoff; Prapasri Sinswat; Keith P Johnston; Robert O Williams
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Monitoring ibuprofen release from multiparticulates: in situ fiber-optic technique versus the HPLC method: a technical note.

Authors:  Vishal Bijlani; Domotiere Yuonayel; Sabitha Katpally; Beatrice Nkem Chukwumezie; Moji Christianah Adeyeye
Journal:  AAPS PharmSciTech       Date:  2007-07-06       Impact factor: 3.246

5.  Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic.

Authors:  Wenzhan Yang; Melgardt M de Villiers
Journal:  AAPS J       Date:  2005-09-02       Impact factor: 4.009

6.  Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.

Authors:  True L Rogers; Andrew C Nelsen; Marazban Sarkari; Timothy J Young; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

7.  Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles.

Authors:  Takuto Mizoe; Tetsuya Ozeki; Hiroaki Okada
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

8.  Investigation of processing parameters of spray freezing into liquid to prepare polyethylene glycol polymeric particles for drug delivery.

Authors:  Melisa K Barron; Timothy J Young; Keith P Johnston; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

9.  Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.

Authors:  Josh D Engstrom; Jasmine M Tam; Maria A Miller; Robert O Williams; Keith P Johnston
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

10.  Solubility Enhancement of a Poorly Water Soluble Drug by Forming Solid Dispersions using Mechanochemical Activation.

Authors:  I Rojas-Oviedo; B Retchkiman-Corona; C T Quirino-Barreda; J Cárdenas; P S Schabes-Retchkiman
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.